News / 

Biden bid on cancer research gets boost in spending deal



This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

WASHINGTON (AP) — Vice President Joe Biden's self-described "moonshot" to cure cancer is getting a modest boost from a congressional deal on federal spending.

The spending-and-taxes package moving through Congress includes a $2 billion increase for the National Institutes of Health. There's also $200 million for research into precision medicine, in which disease treatment is customized to the patient. Some of those funds are designated for precision oncology and genomics.

Biden's office says he worked with key lawmakers to help secure the funding.

In his October speech announcing he wouldn't run for president, Biden said he'd spend his last year in office pushing for more research and development to end cancer. He hasn't yet laid out a comprehensive plan to accomplish that.

Biden's eldest son, Beau Biden, died from brain cancer in May.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Josh Lederman

    SIGN UP FOR THE KSL.COM NEWSLETTER

    Catch up on the top news and features from KSL.com, sent weekly.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast